Post by
FactFinder1994 on Apr 29, 2021 5:54pm
Four FDA submissions ++
With only a hundred million dollar market cap, success has not even begun to be priced in yet.
SQI's multiplex IP's alone are worth more than the current M/C.
The new "surface tech" is worth more then the current M/C.
Each of the four FDA submissions/Approvals are independently worth more that the current M/C.
If not for an under the radar strategy, and the easy manipulation (value suppression) activities as a result, this stock would already be multiples higher than current market cap.
The assets of the company are solid - The only risk is not sharing the story, and therefore allowing the manipulation to continue.
Comment by
Lennoc on Apr 30, 2021 6:14pm
Factfinder, I agree. The M/C is too low along with the share price. I have picked up a few shares down here but I would like to see the share price reflect the true value of the company. I sure once we get a few FDA approvals the share price will double.